Breast Cancer Clinical Trials in Cleveland

Showing 281-300 of 356 trials

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

NCT00632541

Prior clinical trials involving bevacizumab and sorafenib have demonstrated single agent activity in previously treated advanced breast cancer. This trial will test combined VEGF inhibition with sorafenib and bevacizumab in less heavily pre-treated patients with advanced breast cancer.

Metastatic Breast Cancer

Hoosier Cancer Research Network18 participantsStarted Oct 2007

Galesburg, Illinois, United States • Evansville, Indiana, United States • Fort Wayne, Indiana, United States +7 more locations

COMPLETEDPHASE249 miles

NOLAN: Naproxen or Loratadine and Neulasta

NCT01712009

The primary objective of the study is to estimate the difference in bone pain between breast cancer patients receiving chemotherapy and pegfilgrastim and either no prophylactic intervention, prophylactic naproxen, or prophylactic loratadine.

Bone Pain in Stage I - III Breast Cancer

Amgen600 participantsStarted Nov 2012

Muscle Shoals, Alabama, United States • Anaheim, California, United States • Fullerton, California, United States +80 more locations

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

NOLAN: Naproxen or Loratadine and Neulasta

Breast Cancer Trials in Other Cities

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer

Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer

A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function

LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer

Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer

Digital Mammography Screening Trial (ACRIN6652)

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation

Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients

Ixabepilone + Carboplatin Metastatic Breast Cancer

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Immediate Postmastectomy Breast Reconstruction (Strattice Breast)

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Other Conditions in Cleveland